Jaro Wex

Background

About Jaro Wex

Over 10 years’ experience in providing market access solutions for pharmaceutical companies working with global, UK and European affiliates. Currently focusing on evidence development for HTA submissions in oncology and oncology-haematology, cost-effectivenss, cancer treatment pathways, cancer care commissioning and health policy in oncology. Development, management and implementation of health economics and outcomes research projects, such as evidence reviews, evidence syntheses, evidence gap analyses, health economic evaluations, PRO reviews, economic sections for regulatory submissions, global value dossiers, analysis of RCT data, clinical trial design, real world database studies, competitive landscape analysis, pricing and reimbursement analysis, health policy insights, stakeholder research and engagement. Audit of third-party deliverables, advisory boards. Unique combination of clinical, economic, health policy, public relations, statistical, IT and management expertise. Creativity and innovativeness in designing, developing and implementing bespoke market access solutions: from brainstorming, feasibility studies and prototype tools to value demonstration and dissemination. Flexibility and responsiveness, with a personal approach and passion about new challenges. Therapy areas: colorectal cancer, gastric cancer, prostate cancer, breast cancer, non-small cell lung carcinoma, melanoma, non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukaemia (CLL), acute myeloid leukaemia (AML), multiple myeloma, asthma, COPD, IVF, preterm labour, contraception, diabetes, chronic kidney disease, liver disease, stroke, ADHD, Alzheimer’s disease, MRSA, HIV, toxoplasmosis, Fabry “ "It isn’t that they can’t see the solution. It is that they can’t see the problem." G. K. Chesterton "If a man will begin with certainties, he shall end in doubts; but if he will be content to begin with doubts, he shall end in certainties.” F. Bacon Creator of